Literature DB >> 15078934

Integrin alphavbeta8 functions as a receptor for foot-and-mouth disease virus: role of the beta-chain cytodomain in integrin-mediated infection.

Terry Jackson1, Stuart Clark, Stephen Berryman, Alison Burman, Stephanie Cambier, Dezhi Mu, Stephen Nishimura, Andrew M Q King.   

Abstract

Field isolates of foot-and-mouth disease virus (FMDV) have been shown to use three alphav integrins, alphavbeta1, alphavbeta3, and alphavbeta6, as cellular receptors. Binding to the integrin is mediated by a highly conserved RGD motif located on a surface-exposed loop of VP1. The RGD tripeptide is recognized by several other members of the integrin family, which therefore have the potential to act as receptors for FMDV. Here we show that SW480 cells are made susceptible to FMDV following transfection with human beta8 cDNA and expression of alphavbeta8 at the cell surface. The involvement of alphavbeta8 in infection was confirmed by showing that virus binding and infection of the transfected cells are inhibited by RGD-containing peptides and by function-blocking monoclonal antibodies specific for either the alphavbeta8 heterodimer or the alphav chain. Similar results were obtained with a chimeric alphavbeta8 including the beta6 cytodomain (alphavbeta8/6), showing that the beta6 cytodomain can substitute efficiently for the corresponding region of beta8. In contrast, virus binding to alphavbeta6 including the beta8 cytodomain (alphavbeta6/8) was lower than that of the wild-type integrin, and this binding did not lead to infection. Further, the alphavbeta6 chimera was recognized poorly by antibodies specific for the ectodomain of alphavbeta6 and displayed a relaxed sequence-binding specificity relative to that of wild-type integrin. These data suggest that the beta6 cytodomain is important for maintaining alphavbeta6 in a conformation required for productive infection by FMDV.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15078934      PMCID: PMC387692          DOI: 10.1128/jvi.78.9.4533-4540.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

Review 1.  Integrin signaling.

Authors:  F G Giancotti; E Ruoslahti
Journal:  Science       Date:  1999-08-13       Impact factor: 47.728

2.  The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution.

Authors:  R Acharya; E Fry; D Stuart; G Fox; D Rowlands; F Brown
Journal:  Nature       Date:  1989-02-23       Impact factor: 49.962

3.  The pathogenesis of natural and simulated natural foot-and-mouth disease infection in cattle.

Authors:  R Burrows; J A Mann; A J Garland; A Greig; D Goodridge
Journal:  J Comp Pathol       Date:  1981-10       Impact factor: 1.311

4.  Evaluation of genetically engineered derivatives of a Chinese strain of foot-and-mouth disease virus reveals a novel cell-binding site which functions in cell culture and in animals.

Authors:  Qizu Zhao; Juan M Pacheco; Peter W Mason
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

5.  [Is the Arg-Gly-Asp sequence the site for foot-and-mouth disease virus binding with cell receptor?].

Authors:  A Iu Surovoĭ; V T Ivanov; A V Chepurkin; V N Ivaniushchenkov; N N Driagalin
Journal:  Bioorg Khim       Date:  1988-07

6.  The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid).

Authors:  G Fox; N R Parry; P V Barnett; B McGinn; D J Rowlands; F Brown
Journal:  J Gen Virol       Date:  1989-03       Impact factor: 3.891

7.  Integrin alphavbeta8-mediated activation of transforming growth factor-beta inhibits human airway epithelial proliferation in intact bronchial tissue.

Authors:  Lars Fjellbirkeland; Stephanie Cambier; V Courtney Broaddus; Arthur Hill; Paul Brunetta; Gregory Dolganov; David Jablons; Stephen L Nishimura
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

8.  Foot-and-mouth disease virus receptors: comparison of bovine alpha(V) integrin utilization by type A and O viruses.

Authors:  Hernando Duque; Barry Baxt
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

9.  Analysis of neutralizing epitopes on foot-and-mouth disease virus.

Authors:  E Pfaff; H J Thiel; E Beck; K Strohmaier; H Schaller
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

Review 10.  Molecular epidemiology of foot-and-mouth disease virus.

Authors:  N J Knowles; A R Samuel
Journal:  Virus Res       Date:  2003-01       Impact factor: 3.303

View more
  63 in total

Review 1.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  Picornaviruses.

Authors:  Tobias J Tuthill; Elisabetta Groppelli; James M Hogle; David J Rowlands
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

3.  Dissociation of HSV gL from gH by αvβ6- or αvβ8-integrin promotes gH activation and virus entry.

Authors:  Tatiana Gianni; Raffaele Massaro; Gabriella Campadelli-Fiume
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-08       Impact factor: 11.205

4.  TGF-β sequestration by mesangial cell integrin αvβ8: A novel mechanism of glomerular endothelial cell regulation.

Authors:  Ambra Pozzi; Roy Zent
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

5.  Foot-and-mouth disease virus replicates only transiently in well-differentiated porcine nasal epithelial cells.

Authors:  Pradyot Dash; Paul V Barnett; Michael S Denyer; Terry Jackson; Catrina M A Stirling; Philippa C Hawes; Jennifer L Simpson; Paul Monaghan; Haru-H Takamatsu
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

6.  Tropism-modified AAV vectors overcome barriers to successful cutaneous therapy.

Authors:  Jessica Sallach; Giovanni Di Pasquale; Fernando Larcher; Nadine Niehoff; Matthias Rübsam; Anke Huber; Jay Chiorini; David Almarza; Sabine A Eming; Hikmet Ulus; Stephen Nishimura; Ulrich T Hacker; Michael Hallek; Carien M Niessen; Hildegard Büning
Journal:  Mol Ther       Date:  2014-01-28       Impact factor: 11.454

7.  Interactions of foot-and-mouth disease virus with soluble bovine alphaVbeta3 and alphaVbeta6 integrins.

Authors:  Hernando Duque; Michael LaRocco; William T Golde; Barry Baxt
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  A single amino acid substitution in the capsid of foot-and-mouth disease virus can increase acid lability and confer resistance to acid-dependent uncoating inhibition.

Authors:  Miguel A Martín-Acebes; Verónica Rincón; Rosario Armas-Portela; Mauricio G Mateu; Francisco Sobrino
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

9.  A dominant-negative mutant of rab5 inhibits infection of cells by foot-and-mouth disease virus: implications for virus entry.

Authors:  Helen L Johns; Stephen Berryman; Paul Monaghan; Graham J Belsham; Terry Jackson
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

10.  The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy.

Authors:  Xinjie Lu; Dong Lu; Mike Scully; Vijay Kakkar
Journal:  Perspect Medicin Chem       Date:  2008-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.